Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Basic Science

Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse

Axel Rominger, Björn Wängler, Peter Bartenstein and Paul Cumming
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 105;
Axel Rominger
1Dept. of Nuclear Medicine, University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Björn Wängler
1Dept. of Nuclear Medicine, University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
1Dept. of Nuclear Medicine, University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Cumming
1Dept. of Nuclear Medicine, University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 105

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Axel Rominger1,
  2. Björn Wängler1,
  3. Peter Bartenstein1 and
  4. Paul Cumming1
  1. 1Dept. of Nuclear Medicine, University of Munich, Munich, Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2015 to April 2025

AbstractFullPdf
Mar 2015200
May 2015400
Aug 2015300
Sep 2015500
Feb 2016200
Jun 2016200
Jul 2016100
Aug 2016100
Nov 2016200
Dec 2016100
Jan 2017300
Feb 2017300
Mar 2017300
Jun 2017100
Jul 2017100
Sep 2017200
Oct 2017300
Nov 2017400
Jan 2018400
Mar 2018100
May 2018100
Jun 2018200
Sep 2018900
Oct 2018100
Nov 2018100
Dec 2018200
Sep 2019200
Oct 2019200
Dec 2019100
Jan 2020100
Feb 2020400
Mar 20201300
Apr 2020800
Jun 2020100
Aug 20202900
Sep 20205300
Oct 20201900
Nov 20201400
Dec 2020800
Jan 2021600
Feb 2021700
Mar 2021600
Apr 2021700
May 2021500
Jun 2021200
Jul 20211000
Aug 20212100
Sep 20211100
Oct 20212100
Nov 20214600
Dec 20212800
Jan 20226200
Feb 20221500
Mar 20221000
Apr 2022400
May 20221500
Jun 2022100
Aug 2022100
Sep 2022100
Oct 2022200
Nov 2022200
Dec 2022100
Jan 2023800
Feb 2023200
Mar 2023300
Apr 2023200
May 2023300
Jun 2023300
Jul 2023200
Aug 2023200
Sep 2023100
Oct 2023500
Nov 2023100
Dec 2023200
Jan 2024700
Feb 2024200
Mar 2024400
Apr 2024400
May 2024200
Jun 2024500
Jul 2024100
Aug 2024900
Sep 2024900
Nov 2024600
Dec 2024700
Jan 2025400
Feb 2025800
Mar 2025800
Apr 20251000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse
Axel Rominger, Björn Wängler, Peter Bartenstein, Paul Cumming
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 105;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse
Axel Rominger, Björn Wängler, Peter Bartenstein, Paul Cumming
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 105;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Basic Science

  • A new quantitative approach for dopamine transporter binding using [11C]PE2I and PET allowing BBB-penetrating radiolabeled metabolite
  • Measurement of 5-HT1A receptor density and in vivo KD of [F-18]Mefway in the nonhuman primate
  • Activity-related changes in brain HDAC with [F-18]FAHA PET in rats and monkeys
Show more Neurosciences: Basic Science

Basic Science: Emerging Targets

  • In vivo distribution of human brain aromatase with [11C]vorozole
  • Initial PET evaluation of [F-18]fluoro-HEAT for central alpha-1 noradrenergic receptor imaging
Show more Basic Science: Emerging Targets

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire